Clinical Trial

Moringa Oleifera and Phoenix Dactylifera L. Effects on Cortisol and Breast Milk in Postpartum Depression

Completed
View on ClinicalTrials.gov →
Summary
Postpartum depression affects 10-20% of new mothers globally, potentially disrupting breast milk production. This study aimed to provide valuable insights into effective interventions to improve the health and well-being of Postpartum Mothers with depression. This study used a randomized controlled trial design with three groups: intervention 1 (dates), intervention 2 (Moringa oleifera), and a control group. A total of 363 postpartum mothers participated, and data were collected through salivary cortisol levels (ELISA) and Beck Depression Inventory (BDI) scores to measure depression levels and breast milk production (ACIS AC-15X digital scale and Crown electric breast pump) before and after the intervention for 28 days. Data analysis was performed using paired sample t-test and the independent t-test.
Trial Details
NCT Number NCT07337512
Lead Sponsor Melania Asi
Collaborators: Indonesia-MoH
Conditions Postpartum Depression (PPD)
Enrollment 363 participants
Start Date 2024-05-19
Primary Completion 2024-11-19 (estimated)
Study Completion 2024-11-19 (estimated)
Updated on ClinicalTrials.gov 2026-01-13